The Efficacy of rhBMP-2 for Posterolateral Lumbar Fusion in Smokers
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
STUDY DESIGN: Retrospective review of prospectively collected data, as part of an IRB-approved, FDA-regulated, randomized, nonblinded IDE trial of rhBMP-2 matrix for lumbar spinal fusion. OBJECTIVES: The purpose of this study is to examine the influence of smoking on fusion rate and outcome in a large series of patients treated with an rhBMP-2 matrix (AMPLIFY) or iliac crest bone graft as part of a randomized IDE trial for single-level lumbar fusion. SUMMARY OF BACKGROUND DATA: Preclinical studies suggest that bone morphogenetic proteins (BMPs) are able to reverse the negative influence of nicotine on fusion healing in animal models. It remains unclear if a similar benefit will be seen in humans, and if so, what formulation and amount of BMP will be required to achieve that improvement. METHODS: We reviewed the clinical and radiographic records of 148 patients who underwent single-level instrumented lumbar fusion at three spine centers as part of an ongoing FDA-regulated IDE trial. Clinical outcome measures included Oswestry Disability Index, SF-36, back, and leg pain scores. Radiographic measures were plain radiographs with flexion-extension views and fine cut computed tomography scans with sagittal and coronal reconstruction. Fusion success was determined by independent radiologist readings. RESULTS: At 2 years postoperatively, solid fusion was demonstrated in all 55 nonsmokers in the rhBMP-2 group (100%). Successful fusion was seen in 20 of 21 smokers in the rhBMP-2 group (95.2%). Fusion was achieved in 48 of 51 nonsmokers in the iliac crest bone graft (ICBG) group (94.1%), but only 16 of 21 smokers (76.2%) in the ICBG group. CONCLUSIONS: The results of this study suggest that rhBMP-2 may enhance fusion rate in cigarette smokers undergoing single-level instrumented posterolateral lumbar fusion. Despite the improvement in fusion rate with rhBMP-2, clinical outcomes measures were still adversely affected in smokers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., Li, J. H., Wang, H., Yang, H., Ulloa, L., et al. (2003) · Nature · doi:10.1038/nature01339 · Cited by 3,228 · cited 1×
“More recently, nicotine receptors with an anti-inflammatory function have been identified.(20,21) Given the known inhibition of spine fusion associated with nonsteroidal antiinflammatory medications, this pathway may represent an additional mechanism whereby nicotine interferes with fusion healing.”
Background
Cited by
Carragee, E. J., Hurwitz, E. L., & Weiner, B. K. (2011) · The Spine Journal · doi:10.1016/j.spinee.2011.04.023 · Cited by 1,395
A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2
James, A. W., LaChaud, G., Shen, J., Asatrian, G., Nguyen, V., Zhang, X., Ting, K., & Soo, C. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0357 · Cited by 1,131
Fu, R., Selph, S., McDonagh, M., Peterson, K., Tiwari, A., Chou, R., & Helfand, M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-12-201306180-00006 · Cited by 446
Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery
Tannoury, C. A., & An, H. S. (2014) · The Spine Journal · doi:10.1016/j.spinee.2013.08.060 · Cited by 433
FDA-approved bone grafts and bone graft substitute devices in bone regeneration
Gillman, C. E., & Jayasuriya, A. C. (2021) · Materials Science and Engineering: C · doi:10.1016/j.msec.2021.112466 · Cited by 417
Metadata
- Authors
- Glassman, S. D., Dimar, J. R., Burkus, K., Hardacker, J. W., Pryor, P. W., Boden, S. D., & Carreon, L. Y.
- Venue
- Spine
- Published
- 2007-07
- Volume
- 32
- Issue
- 15
- Pages
- 1693-1698
- ISSN
- 0362-2436 (ISSN-L)
- OpenAlex
- W1970221292
- Cited by
- 143
- References
- 1
- FWCI
- 5.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Efficacy of rhBMP-2 for Posterolateral Lumbar Fusion in Smokers. https://app.cochat.ai/papers/10.1097/brs.0b013e318074c366
- The paper
- Glassman, S. D., Dimar, J. R., Burkus, K., Hardacker, J. W., Pryor, P. W., Boden, S. D., & Carreon, L. Y. (2007). The Efficacy of rhBMP-2 for Posterolateral Lumbar Fusion in Smokers. Spine. https://doi.org/10.1097/brs.0b013e318074c366
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.